Search results
Results from the WOW.Com Content Network
Cannabis use disorder ( CUD ), also known as cannabis addiction or marijuana addiction, is a psychiatric disorder defined in the fifth revision of the Diagnostic and Statistical Manual of Mental Disorders ( DSM-5) and ICD-10 as the continued use of cannabis despite clinically significant impairment. [ 2][ 3]
The more recently published DSM-5 combined substance abuse and substance dependence into a single continuum; this is simply known as substance use disorder and requires more presenting symptoms before a diagnosis is made. It also considers each different substance as its own separate disorder, based upon the same basic criteria.
Cannabis use and trauma. Cannabis use and trauma is the contribution that trauma plays in promoting the use and potential abuse of cannabis. [1] Conversely, cannabis use has been associated with the intensity of trauma and PTSD symptoms. [2] [3] While evidence of efficacious use of cannabis is growing in novelty, it is not currently recommended.
Nystagmus. Nystagmus is a condition of involuntary (or voluntary, in some cases) [1] eye movement. [2] People can be born with it but more commonly acquire it in infancy or later in life. In many cases it may result in reduced or limited vision. [3] In normal eyesight, while the head rotates about an axis, distant visual images are sustained by ...
291.x Alcohol-induced psychotic disorder. .5 With delusions. .3 With hallucinations. 291.89 Alcohol-induced mood disorder (coded 291.8 in the DSM-IV) 291.89 Alcohol-induced anxiety disorder (coded 291.8 in the DSM-IV) 291.89 Alcohol-induced sexual dysfunction (coded 291.8 in the DSM-IV)
[34]: 11 Expressed in terms of odds ratio, another study found that "Daily cannabis use was associated with increased odds of psychotic disorder compared with never users (adjusted odds ratio [OR] 3.2, 95% CI 2.2–4.1), increasing to nearly five-times increased odds for daily use of high-potency types of cannabis (4.8, 2.5–6.3)."
DSM-5 online. The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition ( DSM-5 ), is the 2013 update to the Diagnostic and Statistical Manual of Mental Disorders, the taxonomic and diagnostic tool published by the American Psychiatric Association (APA). In 2022, a revised version (DSM-5-TR) was published. [ 1]
According to recent research, semaglutide drugs, such as Ozempic and Wegovy, are linked to a lower risk of cognitive problems, as well as reduced cravings for nicotine.